Tocilizumab: A new opportunity in the possible therapeutic arsenal against COVID-19.
Identifieur interne : 000049 ( Main/Exploration ); précédent : 000048; suivant : 000050Tocilizumab: A new opportunity in the possible therapeutic arsenal against COVID-19.
Auteurs : Yeimer Ortiz-Martínez [Colombie]Source :
- Travel medicine and infectious disease [ 1873-0442 ] ; 2020.
DOI: 10.1016/j.tmaid.2020.101678
PubMed: 32325121
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000032
- to stream PubMed, to step Curation: 000032
- to stream PubMed, to step Checkpoint: 000027
- to stream Ncbi, to step Merge: 002C42
- to stream Ncbi, to step Curation: 002C42
- to stream Ncbi, to step Checkpoint: 002C42
- to stream Main, to step Merge: 000049
- to stream Main, to step Curation: 000049
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Tocilizumab: A new opportunity in the possible therapeutic arsenal against COVID-19.</title><author><name sortKey="Ortiz Martinez, Yeimer" sort="Ortiz Martinez, Yeimer" uniqKey="Ortiz Martinez Y" first="Yeimer" last="Ortiz-Martínez">Yeimer Ortiz-Martínez</name><affiliation wicri:level="1"><nlm:affiliation>Internal Medicine Department, Universidad Industrial de Santander, Bucaramanga, Colombia; Faculty of Health Sciences, Universidad de Sucre, Sincelejo, Colombia. Electronic address: yeimer10@hotmail.com.</nlm:affiliation><country xml:lang="fr">Colombie</country><wicri:regionArea>Internal Medicine Department, Universidad Industrial de Santander, Bucaramanga, Colombia; Faculty of Health Sciences, Universidad de Sucre, Sincelejo</wicri:regionArea><wicri:noRegion>Sincelejo</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32325121</idno><idno type="pmid">32325121</idno><idno type="doi">10.1016/j.tmaid.2020.101678</idno><idno type="wicri:Area/PubMed/Corpus">000032</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000032</idno><idno type="wicri:Area/PubMed/Curation">000032</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000032</idno><idno type="wicri:Area/PubMed/Checkpoint">000027</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000027</idno><idno type="wicri:Area/Ncbi/Merge">002C42</idno><idno type="wicri:Area/Ncbi/Curation">002C42</idno><idno type="wicri:Area/Ncbi/Checkpoint">002C42</idno><idno type="wicri:Area/Main/Merge">000049</idno><idno type="wicri:Area/Main/Curation">000049</idno><idno type="wicri:Area/Main/Exploration">000049</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Tocilizumab: A new opportunity in the possible therapeutic arsenal against COVID-19.</title><author><name sortKey="Ortiz Martinez, Yeimer" sort="Ortiz Martinez, Yeimer" uniqKey="Ortiz Martinez Y" first="Yeimer" last="Ortiz-Martínez">Yeimer Ortiz-Martínez</name><affiliation wicri:level="1"><nlm:affiliation>Internal Medicine Department, Universidad Industrial de Santander, Bucaramanga, Colombia; Faculty of Health Sciences, Universidad de Sucre, Sincelejo, Colombia. Electronic address: yeimer10@hotmail.com.</nlm:affiliation><country xml:lang="fr">Colombie</country><wicri:regionArea>Internal Medicine Department, Universidad Industrial de Santander, Bucaramanga, Colombia; Faculty of Health Sciences, Universidad de Sucre, Sincelejo</wicri:regionArea><wicri:noRegion>Sincelejo</wicri:noRegion></affiliation></author></analytic><series><title level="j">Travel medicine and infectious disease</title><idno type="eISSN">1873-0442</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader></TEI><affiliations><list><country><li>Colombie</li></country></list><tree><country name="Colombie"><noRegion><name sortKey="Ortiz Martinez, Yeimer" sort="Ortiz Martinez, Yeimer" uniqKey="Ortiz Martinez Y" first="Yeimer" last="Ortiz-Martínez">Yeimer Ortiz-Martínez</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000049 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000049 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32325121
|texte= Tocilizumab: A new opportunity in the possible therapeutic arsenal against COVID-19.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32325121" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a TocilizumabV1
| This area was generated with Dilib version V0.6.34. |  |